Massimiliano is an international finance and commercial executive and corporate advisor with extensive experience in pharma, biotech, and MedTech.
He has held senior leadership roles in Finance & Investor Relations, Business Development, Marketing, and Commercial Operations, including National BU Head, Regional Franchise Head (Europe & Canada) in big pharma companies such as Eli Lilly and Takeda, and Chief Marketing Officer for a clinical-stage biotech.
He advises start-ups, established companies, and investors on strategy, fundraising, and international expansion, with a strong focus on health innovation and transformative technologies.
Massimiliano holds a Master’s degree in Economics and Finance, an MBA from LUISS Business School, and an Executive Master’s from Columbia University.
He is also a business angel and accredited investor focused on early-stage ventures in biotech, MedTech, AI, and digital health.